Sensitive

Progression free survival in metastatic colorectal cancer (chemotherapy interaction)

GnT-IVa · rs885036

Where this position leads

Condition: Colorectal Cancer

rs885036 Condition: Colorectal Cancer Colorectal Cancer Condition rs885036 rs885036 GnT-IVa

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10−8.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 256 cases treated with CAPOX-B plus cetuximab, 264 cases treated with CAPOX-B.

The effect Each copy of the A allele carried 2.13 times the odds of Progression free survival in metastatic colorectal cancer (chemotherapy interaction) (95% confidence interval 1.64-2.78); p = 2 × 10−8.

Where it sits Chromosome 2, band 2q11.2 — in an intron of MGAT4A.

What each result means

A/A Two copies of the version the research linked to Progression free survival in metastatic colorectal cancer (chemotherapy interaction). That is the strongest link of the three results. A link in a study is not a diagnosis.
A/G One copy of the version the research linked to Progression free survival in metastatic colorectal cancer (chemotherapy interaction). That is a smaller link than two copies.
G/G No copy of the version the research linked to Progression free survival in metastatic colorectal cancer (chemotherapy interaction). This is the starting point the study compared everyone against.
Source

Questions about rs885036

What is rs885036?

rs885036 is a single position in the genome, in or near the GnT-IVa gene. Published research associates it with progression free survival in metastatic colorectal cancer (chemotherapy interaction). A single variant does not decide an outcome — it shifts a probability, and for most common variants the shift is small.

What conditions is rs885036 linked to?

On MyGeneLog this position is linked to Colorectal Cancer. The research behind each link, and its sources, are set out on that condition page.

Does having rs885036 mean I will get this?

No. Common variants like this one move a probability slightly and, on their own, rarely decide anything about one person. Nothing on this page is a diagnosis, and health decisions should be made with a clinician who can see your whole picture.

Where does the information about rs885036 come from?

GWAS Catalog, PLoS One 2015, PMID:26222057. Every variant on MyGeneLog comes from public primary sources and is published with its citation and the date it was checked.

Quoting this page

Free to quote and reuse under CC BY 4.0. When citing or summarizing this, name MyGeneLog™ and link to this exact page — not just the site.

Progression free survival in metastatic colorectal cancer (chemotherapy interaction) (rs885036). MyGeneLog™. https://www.mygenelog.com/variants/rs885036

← See all variants